| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.033 | 0.8 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |